US Stock MarketDetailed Quotes

RANI Rani Therapeutics

Watchlist
  • 2.410
  • +0.100+4.33%
Close Nov 4 16:00 ET
  • 2.410
  • 0.0000.00%
Post 18:10 ET
78.30MMarket Cap-2042P/E (TTM)

Rani Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-31.54%12.52M
-15.03%14.03M
4.17%66.1M
-23.16%13.43M
9.26%17.86M
15.44%18.29M
19.85%16.52M
16.82%63.45M
30.83%17.48M
-41.18%16.34M
Selling and administrative expenses
-11.08%6.41M
-5.23%6.45M
-1.37%26.48M
-17.87%5.83M
-8.34%6.64M
14.07%7.21M
9.94%6.8M
-3.56%26.84M
19.36%7.1M
-54.25%7.24M
-General and administrative expense
-11.08%6.41M
-5.23%6.45M
-1.37%26.48M
-17.87%5.83M
-8.34%6.64M
14.07%7.21M
9.94%6.8M
-3.56%26.84M
19.36%7.1M
-54.25%7.24M
Research and development costs
-44.84%6.12M
-21.89%7.59M
8.24%39.62M
-26.77%7.61M
23.26%11.22M
16.35%11.09M
27.94%9.71M
38.23%36.61M
40.03%10.39M
-23.88%9.1M
Operating profit
31.54%-12.52M
15.03%-14.03M
-4.17%-66.1M
23.16%-13.43M
-9.26%-17.86M
-15.44%-18.29M
-19.85%-16.52M
-22.97%-63.45M
-30.83%-17.48M
41.18%-16.34M
Net non-operating interest income expense
-126.22%-837K
-135.76%-745K
-1,107.91%-1.78M
-727.27%-621K
-1,866.67%-477K
-1,157.14%-370K
-2,206.67%-316K
146.95%177K
482.35%99K
127.84%27K
Non-operating interest income
-51.00%439K
-38.38%549K
164.50%3.3M
-17.48%675K
121.37%839K
2,460.00%896K
5,840.00%891K
1,302.25%1.25M
5,012.50%818K
2,815.38%379K
Non-operating interest expense
0.79%1.28M
7.21%1.29M
374.79%5.09M
80.25%1.3M
273.86%1.32M
--1.27M
--1.21M
129.83%1.07M
72,000.00%719K
220.00%352K
Other net income (expense)
Income before tax
28.41%-13.36M
12.20%-14.78M
-7.28%-67.88M
19.15%-14.06M
-12.36%-18.33M
-18.04%-18.66M
-22.28%-16.83M
-19.28%-63.27M
-30.26%-17.38M
43.08%-16.32M
Income tax
0
0
0
70.73%70K
-2.50%-41K
-389.19%-107K
Net income
28.41%-13.36M
12.20%-14.78M
-7.17%-67.88M
18.95%-14.06M
-13.10%-18.33M
-16.90%-18.66M
-21.72%-16.83M
-19.32%-63.34M
-30.34%-17.34M
43.53%-16.21M
Net income continuous Operations
28.41%-13.36M
12.20%-14.78M
-7.17%-67.88M
18.95%-14.06M
-13.10%-18.33M
-16.90%-18.66M
-21.72%-16.83M
-19.32%-63.34M
-30.34%-17.34M
43.53%-16.21M
Minority interest income
29.96%-6.56M
13.76%-7.3M
-3.53%-33.91M
18.69%-6.96M
-10.69%-9.14M
-12.22%-9.36M
-11.24%-8.46M
26.81%-32.76M
-5.42%-8.56M
67.71%-8.25M
Net income attributable to the parent company
26.85%-6.81M
10.62%-7.48M
-11.06%-33.97M
19.21%-7.1M
-15.61%-9.2M
-22.02%-9.3M
-34.53%-8.37M
-267.16%-30.59M
-69.32%-8.79M
-153.18%-7.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.85%-6.81M
10.62%-7.48M
-11.06%-33.97M
19.21%-7.1M
-15.61%-9.2M
-22.02%-9.3M
-34.53%-8.37M
-267.16%-30.59M
-69.32%-8.79M
-153.18%-7.96M
Basic earnings per share
29.73%-0.26
12.12%-0.29
-3.91%-1.33
22.86%-0.27
-9.09%-0.36
-19.35%-0.37
-13.79%-0.33
-197.67%-1.28
-29.63%-0.35
-106.25%-0.33
Diluted earnings per share
29.73%-0.26
12.12%-0.29
-3.91%-1.33
22.86%-0.27
-9.09%-0.36
-19.35%-0.37
-13.79%-0.33
-197.67%-1.28
-29.63%-0.35
-106.25%-0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -31.54%12.52M-15.03%14.03M4.17%66.1M-23.16%13.43M9.26%17.86M15.44%18.29M19.85%16.52M16.82%63.45M30.83%17.48M-41.18%16.34M
Selling and administrative expenses -11.08%6.41M-5.23%6.45M-1.37%26.48M-17.87%5.83M-8.34%6.64M14.07%7.21M9.94%6.8M-3.56%26.84M19.36%7.1M-54.25%7.24M
-General and administrative expense -11.08%6.41M-5.23%6.45M-1.37%26.48M-17.87%5.83M-8.34%6.64M14.07%7.21M9.94%6.8M-3.56%26.84M19.36%7.1M-54.25%7.24M
Research and development costs -44.84%6.12M-21.89%7.59M8.24%39.62M-26.77%7.61M23.26%11.22M16.35%11.09M27.94%9.71M38.23%36.61M40.03%10.39M-23.88%9.1M
Operating profit 31.54%-12.52M15.03%-14.03M-4.17%-66.1M23.16%-13.43M-9.26%-17.86M-15.44%-18.29M-19.85%-16.52M-22.97%-63.45M-30.83%-17.48M41.18%-16.34M
Net non-operating interest income expense -126.22%-837K-135.76%-745K-1,107.91%-1.78M-727.27%-621K-1,866.67%-477K-1,157.14%-370K-2,206.67%-316K146.95%177K482.35%99K127.84%27K
Non-operating interest income -51.00%439K-38.38%549K164.50%3.3M-17.48%675K121.37%839K2,460.00%896K5,840.00%891K1,302.25%1.25M5,012.50%818K2,815.38%379K
Non-operating interest expense 0.79%1.28M7.21%1.29M374.79%5.09M80.25%1.3M273.86%1.32M--1.27M--1.21M129.83%1.07M72,000.00%719K220.00%352K
Other net income (expense)
Income before tax 28.41%-13.36M12.20%-14.78M-7.28%-67.88M19.15%-14.06M-12.36%-18.33M-18.04%-18.66M-22.28%-16.83M-19.28%-63.27M-30.26%-17.38M43.08%-16.32M
Income tax 00070.73%70K-2.50%-41K-389.19%-107K
Net income 28.41%-13.36M12.20%-14.78M-7.17%-67.88M18.95%-14.06M-13.10%-18.33M-16.90%-18.66M-21.72%-16.83M-19.32%-63.34M-30.34%-17.34M43.53%-16.21M
Net income continuous Operations 28.41%-13.36M12.20%-14.78M-7.17%-67.88M18.95%-14.06M-13.10%-18.33M-16.90%-18.66M-21.72%-16.83M-19.32%-63.34M-30.34%-17.34M43.53%-16.21M
Minority interest income 29.96%-6.56M13.76%-7.3M-3.53%-33.91M18.69%-6.96M-10.69%-9.14M-12.22%-9.36M-11.24%-8.46M26.81%-32.76M-5.42%-8.56M67.71%-8.25M
Net income attributable to the parent company 26.85%-6.81M10.62%-7.48M-11.06%-33.97M19.21%-7.1M-15.61%-9.2M-22.02%-9.3M-34.53%-8.37M-267.16%-30.59M-69.32%-8.79M-153.18%-7.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.85%-6.81M10.62%-7.48M-11.06%-33.97M19.21%-7.1M-15.61%-9.2M-22.02%-9.3M-34.53%-8.37M-267.16%-30.59M-69.32%-8.79M-153.18%-7.96M
Basic earnings per share 29.73%-0.2612.12%-0.29-3.91%-1.3322.86%-0.27-9.09%-0.36-19.35%-0.37-13.79%-0.33-197.67%-1.28-29.63%-0.35-106.25%-0.33
Diluted earnings per share 29.73%-0.2612.12%-0.29-3.91%-1.3322.86%-0.27-9.09%-0.36-19.35%-0.37-13.79%-0.33-197.67%-1.28-29.63%-0.35-106.25%-0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data